These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

914 related items for PubMed ID: 28237123

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K, Churilov L, Weir L, Dong Q, Davis S, Yan B.
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
    [Abstract] [Full Text] [Related]

  • 4. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH, Ali SF, Reeves MJ, Smith EE, Saver JL, Messe S, Bhatt DL, Grau-Sepulveda MV, Peterson ED, Fonarow GC.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):543-9. PubMed ID: 24046398
    [Abstract] [Full Text] [Related]

  • 5. Cluster-Randomized Trial of Thrombolysis Implementation Support in Metropolitan and Regional Australian Stroke Centers: Lessons for Individual and Systems Behavior Change.
    Levi CR, Attia JA, D'Este C, Ryan AE, Henskens F, Kerr E, Parsons MW, Sanson-Fisher RW, Bladin CF, Lindley RI, Middleton S, Paul CL, TIPS (Thrombolysis Implementation in Stroke) Study Group †, TIPS (Thrombolysis Implementation in Stroke) Study Group<xref ref-type="author-note" rid="jah34706-note-1002"><sup>†</sup></xref>.
    J Am Heart Assoc; 2020 Feb 04; 9(3):e012732. PubMed ID: 31973599
    [Abstract] [Full Text] [Related]

  • 6. Analyses of the Turkish National Intravenous Thrombolysis Registry.
    Kutluk K, Kaya D, Afsar N, Arsava EM, Ozturk V, Uzuner N, Giray S, Topcuoglu MA, Gungor L, Sirin H, Yaka E, Ozdemir O, Dalkara T, Turkish Thrombolysis Study Group.
    J Stroke Cerebrovasc Dis; 2016 May 04; 25(5):1041-1047. PubMed ID: 26853139
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Does renal dysfunction modify the effect of intravenous thrombolysis for acute ischemic stroke within 4.5 hours of onset? A multicenter observational study.
    Hsieh CY, Lin HJ, Sung SF, Yang YH, Lai EC, Hsieh HC, Chen CH.
    J Stroke Cerebrovasc Dis; 2015 Mar 04; 24(3):673-9. PubMed ID: 25577428
    [Abstract] [Full Text] [Related]

  • 9. Safety of Intravenous Thrombolysis in Chronic Intracranial Hemorrhage: A Five-Year Multicenter Study.
    Zand R, Tsivgoulis G, Sadighi A, Singh M, McCormack M, Shahjouei S, Goyal N, Noorbakhsh-Sabet N, Alexandrov AW, Alexandrov AV.
    J Stroke Cerebrovasc Dis; 2018 Mar 04; 27(3):620-624. PubMed ID: 29100859
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Correlation of Changes in Leukocytes Levels 24 Hours after Intravenous Thrombolysis With Prognosis in Patients With Acute Ischemic Stroke.
    Chen J, Zhang Z, Chen L, Feng X, Hu W, Ge W, Li X, Jin P, Shao B.
    J Stroke Cerebrovasc Dis; 2018 Oct 04; 27(10):2857-2862. PubMed ID: 30064868
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience.
    Šaňák D, Jakubíček S, Černík D, Herzig R, Kunáš Z, Mikulík R, Ostrý S, Reif M, Rohan V, Tomek A, Veverka T.
    J Stroke Cerebrovasc Dis; 2018 Sep 04; 27(9):2479-2483. PubMed ID: 29807757
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Temporal Trends in Clinical Characteristics and Door-to-Needle Time in Patients Receiving Intravenous Tissue Plasminogen Activator: A Retrospective Study of 4 Hospitals in Japan.
    Tanaka K, Matsumoto S, Yamada T, Nagano S, Takase KI, Hatano T, Yamasaki R, Kira JI.
    J Stroke Cerebrovasc Dis; 2019 Nov 04; 28(11):104305. PubMed ID: 31405791
    [Abstract] [Full Text] [Related]

  • 20. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
    Pretnar Oblak J, Sabovic M, Frol S.
    J Stroke Cerebrovasc Dis; 2019 Mar 04; 28(3):768-773. PubMed ID: 30527792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.